Ceterix Announces FDA Clearance and U.S. Commercial Availability of Next-Generation Meniscus Repair Device

NovoStitch Plus Enables Meniscus Preservation for More Patients MENLO PARK, Calif. – Sept. 22, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. commercial availability of the company’s NovoStitch® Plus […]

Read More


Ceterix Announces Health Economics Data Demonstrating Cost Savings for Meniscus Repair

Data Presented at ISPOR Annual Meeting MENLO PARK, Calif. – May 19, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve a surgeon’s ability to perform minimally invasive orthopaedic procedures, today announced the results of a health economics study related to meniscus surgery, the single most commonly-performed arthroscopic procedure in the […]

Read More


Ceterix Orthopaedics Announces $35 Million In New Funding

MENLO PARK, Calif. – May 7, 2015 – Ceterix® Orthopaedics today announced that it has entered into a term loan agreement with CRG and certain of its affiliate funds, providing Ceterix with up to $35 million of available borrowing capacity. “We are excited to have further support to continue our mission to save the meniscus […]

Read More


Ceterix Announces Publication of Studies Demonstrating Advantages of Meniscus Repair with Minimally Invasive Orthopaedic Suturing Device

Technology Offers Potential to Improve Repairs, Extend Repair to Additional Tear Types MENLO PARK, Calif. – March 06, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue procedures, today announced publication of positive findings from two biomechanical studies of the company’s proprietary NovoStitch® suture passer for meniscus repair […]

Read More


Ceterix Announces Addition of Three New Patents Protecting Technology for Minimally Invasive Orthopaedic Procedures

Intellectual Property Portfolio Totals More Than 180 Issued Claims MENLO PARK, Calif. – January 20, 2015 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive orthopaedic procedures, today announced the issuance of three new patents, adding to the company’s robust patent portfolio. The company’s innovative NovoStitch® suture passer is used in […]

Read More


Ceterix Announces Issuance of Key New Patent for Minimally Invasive Orthopaedic Procedures

Adds to Robust Intellectual Property Portfolio Totaling Over 160 Issued Claims MENLO PARK, Calif. – September 8, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve the ability to perform minimally invasive orthopaedic procedures, today announced the issuance of a new patent adding to the company’s existing patent portfolio. The company’s […]

Read More


New Literature Review Demonstrates Favorable Success Rates for Repairing Horizontal Meniscus Tears

Results Suggest Meniscus Repair May be Feasible for Many Patients MENLO PARK, Calif. – August 18, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced results of a systematic literature review evaluating the success rate of repairing horizontal meniscus tears, a common type of knee injury. Patients with […]

Read More


Ceterix Orthopaedics Completes $18 Million Financing

Company Announces Issuance of Two New U.S. Patents MENLO PARK, Calif. – May 13, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has closed $18 million in new financing. Previous investors Novo A/S, Versant Ventures and 5AM Ventures participated in the round, which also […]

Read More


Ceterix Announces Results from Biomechanical Studies of Minimally Invasive Orthopaedic Suturing Device

MENLO PARK, Calif. – May 1, 2014 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue procedures, today announced positive findings of recent biomechanical studies of the company’s proprietary NovoStitch™ technology. Adam Anz, M.D., of the Andrews Institute in Gulf Breeze, Fla., presented results of a study that evaluated […]

Read More


Ceterix Announces Issuance of Two Key Patents for Minimally Invasive Orthopaedic Suturing

MENLO PARK, California – August 6, 2013 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that expand and improve minimally invasive tissue procedures, today announced the issuance of two key patents for the company’s proprietary technology used in meniscal tear and other soft tissue injury procedures.1,2 Ceterix’s patents describe unique methods and designs […]

Read More


Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures

Featured in Peer-Reviewed Publication Describing Innovative Techniques for Knee Meniscus Repair MENLO PARK, California – July 16, 2013 – Ceterix® Orthopaedics, Inc. today announced commercial availability of the company’s NovoStitch™ suture passer in the United States. The company’s device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, […]

Read More


Ceterix Orthopaedics Completes $19.5 Million Series B Financing

MENLO PARK, California – January 22, 2013 – Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for arthroscopic procedures, today announced that the company has completed a $19.5 million series B financing. The round was led by new investor Novo Ventures. Previous investors Versant Ventures and 5AM Ventures also participated in the round. In […]

Read More


Kevin Sidow Joins Ceterix Orthopaedics Board of Directors as Chairman

MENLO PARK, California – November 2011 – Medical device company, Ceterix® Orthopaedics, Inc., developer of novel surgical tools for arthroscopic procedures, today announced that Kevin Sidow has joined the company’s Board of Directors as Chairman. Mr. Sidow, President and CEO of Moximed, Inc., has over twenty years of orthopaedic medical device experience. Prior to his […]

Read More


SuturePro Technologies Becomes Ceterix Orthopaedics

MENLO PARK, California – April 2011 –SuturePro Technologies, Inc., a medical device company that develops novel surgical tools for arthroscopic procedures, today announced that it has changed its name to Ceterix Orthopaedics. “This new name allows for a broader representation of products the company plans to launch,” said John McCutcheon, Ceterix President and CEO. Ceterix […]

Read More


SuturePro Technologies Closes $8.1 Million Series A Financing

MENLO PARK, CALIFORNIA – October 2010 – Medical device company, SuturePro Technologies, Inc., developer of novel surgical tools for arthroscopic procedures, today announced that it closed an $8.1 million Series A funding. The effort was led by Versant Ventures and 5AM Ventures. “This round of funding is a critical step in further developing the inventions […]

Read More